Conquering Diseases

Investigational Drug Study, Involving Radiation for Patients with Lung Cancer.


Seeking Men and Women over 18 years old who have a certain type of Stage III Non-Small Cell Lung Cancer (NSCLC).


We are studying to • See how well the study drug, pembrolizumab together with 2 different chemotherapy combinations and radiotherapy • Test the safety of the study drug • See how your body handles the study drug

What we're hoping for

We are hoping that the subjects will benefit from the standard of care treatment a well as the study drug. Information learned from the study may help other people in the future.

Additional Information Identifier: NCT03631784

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655